PHOENYCS GO, RCT of dapirplizumab, novel CD40Li in SLE Met primary endpoint (NNT~6 for BICLA) & numerical improvements in many other endpts 1 MI & 1 death from infection over 213 pts Encouraging for sure! Second phase 3 being launched #ACR24 @RheumNow Abstr#L16 #ACRbest https://t.co/QwDMKjhFvb

• https://x.com/EBRheum/status/1858865337334211065/photo/1
• https://x.com/EBRheum/status/1858865337334211065/photo/1
• https://x.com/EBRheum/status/1858865337334211065/photo/1
• https://x.com/EBRheum/status/1858865337334211065/photo/1

It is NO LONGER a ACCEPTABLE To NOT consider #MMF or #Cyclo + another proven #Rx Added to #HCQ and #tapering /limiting #glucocorticoids RCTs in #lupus #nephritis support this ? Is which to add #belimumab #CNI #volclosporin #obinutuzimab #ACR #ACRbest @RheumNow @ACRheum https://t.co/a7WMFfCyXl

• https://twitter.com/mithurheum/status/1858531398711202080

Pathophysiological pathways in neuropsychiatric SLE. 2 components: -Ischaemic -Inflammatory Zahi Touma @RheumNow #ACR24 https://t.co/wwlSSSpOIU

• https://x.com/synovialjoints/status/1858635468436615207/photo/1

Subsets of lupus arthritis. Kenneth Kalunian @RheumNow #ACR24 https://t.co/ZmHui126zr

• https://x.com/synovialjoints/status/1858619265659670978/photo/1

Study by Maria Dall'Era et al. compared voclosporin-based triple immunosuppressive therapy with high-dose GC in active lupus nephritis. - Fewer adverse events in the voclosporin group, despite a higher incidence of specific issues like decreased GFR and hypertension. - 25%… https://t.co/ToRu2rdErC https://t.co/uUXzNNuLDb

• https://x.com/i/web/status/1858608171926814731
• https://x.com/synovialjoints/status/1858608171926814731/photo/1

Loiseau et al. 4700 pSS, 47000 comparators. pSS associated with increased risk of every CV/VTE outcome. Did not have that in my priors! @RheumNow #ACR24 Abstr#2631 https://t.co/QKemUhbcG8 https://t.co/twpjdS2L63

• Risk of Atherosclerotic Cardiovascular Events and Venous Thromboembolism in Peo…
• https://x.com/RichardPAConway/status/1858611134086987820/photo/1

A re-evaluation of lupus arthritis. Old dogma is RA is erosive and SLE non-erosive. With better imaging, lupus arthritis can be erosive. Vivianne Malstrom. @RheumNow #ACR24 https://t.co/JEqVPLGNfu

• https://x.com/synovialjoints/status/1858615163198599273/photo/1

Did you know? #Lupus arthritis have clinical and US classifications. On MRI, findings will show: - periarticular hyperplastic tissue - capsular swelling - edematous tenosynovitis @RheumNow #ACR24 @rheumarhyme @theactiverheum https://t.co/EoKh2Q3V9Z

• https://x.com/RHEUMarampa/status/1858615615248101855/photo/1
• https://x.com/RHEUMarampa/status/1858615615248101855/photo/1

Dr. CStone et al. assessed nailfold dermoscopy in distinguishing DM from SLE Almost all DM pts had nailfold changes in at least 1 digit vs. SLE & majority of DM pts had nailfold changes in all 10 digits Dermoscopy is a simple alternative to capillaroscopy @rheumNow #ACR24 ab2404 https://t.co/6tEXAlX7lt

• https://x.com/RHEUMarampa/status/1858589997844033617/photo/1

Neuropsychiatric manifestations in SLE. Susanne Benseler MD @RheumNow #ACR24 https://t.co/subiykC5Q4

• https://x.com/synovialjoints/status/1858591546930794555/photo/1

Neuroimaging is done to support the diagnosis of CNS #lupus but only 75% reveal abnormal brain MRI. 📌 It is more useful in pts with local deficits than diffuse. 📌 poorly correlated with cognitive dysfunction & psych phenotypes. @Rheumnow #ACR24 @rheumarhyme @theactiverheum https://t.co/HjNbVBaOHv

• https://x.com/RHEUMarampa/status/1858594297068568866/photo/1

The different NPSLE syndromes 👇 Highlighted in yellow are the most common manifestations. 🧠 - Cognitive dysfunction - Mood disorder - Anxiety disorder @RheumNow #ACR24 https://t.co/1I7OVPT6DK

• https://x.com/RHEUMarampa/status/1858594961786368109/photo/1

Diagnostic work up for neuropsychiatric SLE. Zahi Touma MD @RheumNow #ACR24 https://t.co/zLX1QHCaSu

• https://x.com/synovialjoints/status/1858596785477894242/photo/1